Cargando…
Decreased expression of SLC 39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer
OBJECTIVE: Solute carrier family 39, member 14 (SLC39A14), has been identified as a potential biomarker for various cancers. However, its roles in prostate cancer (PCa) are still unclear. The aim of this study was to investigate the clinical significance of SLC39A14 in patients with PCa and its func...
Autores principales: | Xu, Xiao-Ming, Wang, Cheng-Gong, Zhu, Yu-Di, Chen, Wei-Hua, Shao, Si-Liang, Jiang, Fu-Neng, Liao, Qian-De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948725/ https://www.ncbi.nlm.nih.gov/pubmed/27471394 http://dx.doi.org/10.2147/OTT.S103640 |
Ejemplares similares
-
Study on the role of SLC14A1 gene in biochemical recurrence of prostate cancer
por: Ye, Bin, et al.
Publicado: (2022) -
Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023) -
Loss of slc39a14 causes simultaneous manganese hypersensitivity and deficiency in zebrafish
por: Tuschl, Karin, et al.
Publicado: (2022) -
Disruption of the mouse Slc39a14 gene encoding zinc transporter ZIP14 is associated with decreased bone mass, likely caused by enhanced bone resorption
por: Sasaki, Sun, et al.
Publicado: (2018) -
Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
por: Ding, Min, et al.
Publicado: (2023)